Target intelligence / Profile preview

Interleukin-12 (IL-12)

Target
IL-12
Molecular classification
Cytokine, Interleukin
01

Overview

Interleukin-12 (IL-12) is a heterodimeric, pro-inflammatory cytokine that plays a central role in regulating immune responses. It is primarily produced by antigen-presenting cells such as dendritic cells, macrophages, and B lymphocytes in response to pathogens or immune stimuli. IL-12 consists of two covalently linked subunits: p35 and p40. The functional IL-12 receptor is composed of two subunits: IL‑12Rβ1 and IL‑12Rβ2. IL‑12 has several key immunological roles including inducing differentiation of naïve CD4+ T cells into Th1 effector cells, stimulating production of interferon-gamma (IFN‑γ) and tumor necrosis factor-alpha (TNF‑α) from T and NK cells and enhancing cytotoxic activity of CD8+ cytotoxic T lymphocytes (CTLs), natural killer (NK) cells, and NKT-like LAK populations. Therapeutic interest includes cancer immunotherapy, but dysregulated or excessive production can contribute to autoimmune/inflammatory diseases.

02

Mechanism of action

Inhibition of IL-12/IL-23 pathway (for anti-p40 antibodies)

03

Biological functions

Th1 differentiationInterferon-gamma (IFN-γ) productionTumor necrosis factor-alpha (TNF-α) productionCytotoxic T lymphocyte (CTL) activationNatural killer (NK) cell activationImmune response
04

Disease associations

CancerAutoimmune diseasesInflammatory diseasesInfection
05

Safety considerations

Potential for excessive immune stimulationToxicity at high doses

Beyond the preview

Go deeper on Interleukin-12 (IL-12).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Interleukin-12 (IL-12).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call